High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: June 2, 2019
Clear
SKU: GMS834 Category:

The market size of high content screening is projected to reach USD 1.34 billion by 2024, increasing at a CAGR of 9.76% during the forecast period. The key factors expected to drive the high content screening market are the need for cost containment in pharmaceutical R&D, increased funding for cellular research, and technological advances in HCS solutions, which are expected to support the growth of the HCS market during the forecast period.

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 1

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 2

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 3

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 4

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 5

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 6

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 7

High Content Screening Market by Product (Flow Cytometry, Cell Imaging & Analysis System, Software, Consumable, Service) Application (Toxicity Studies, Primary & Secondary Screening, Target Identification & Validation), End User - 2019 to 2024 8

1 Global High Content Screening Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global High Content Screening Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global High Content Screening Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global High Content Screening Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global High Content Screening Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global High Content Screening Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global High Content Screening Market – By Product (Market Size – & million/billion)
8.1 Instruments
8.2 Consumables
8.3 Software
8.4 Services
8.5 Accessories

9 Global High Content Screening Market – By Application
9.1 Target Identification and Validation
9.2 Primary Screening and Secondary Screening
9.3 Toxicity Studies
9.4 Compound Profiling
9.5 Other

10 Global High Content Screening Market – By End-User
10.1 Pharmaceutical and Biotechnology Companies
10.2 Academic and Government Institutes
10.3 Contract Research Organizations (CROs)

11 Global High Content Screening Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global High Content Screening Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global High Content Screening Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Danaher Corporation
13.3 GE Healthcare
13.4 Becton, Dickinson and Company
13.5 Thermo Fisher Scientific Inc.
13.6 Perkinelmer, Inc.
13.7 Merck Millipore
13.8 Tecan Group Ltd.
13.9 Bio-Rad Laboratories, Inc.
13.10 Biotek Instruments, Inc.
13.11 Yokogawa Electric Corporation
13.12 Company 11 & more

14 Global High Content Screening Market – Appendix
14.1 Sources
14.2 Abbreviations